Aseem Anand
Mr. Anand believes in the empowerment of patients with clinically relevant and AI driven biomarkers. As the Vice President and Head of Digital Biomarker Solutions at Lantheus, he is responsible for executing the value-based adoption strategy of AI-enabled biomarkers to deliver better outcomes for patients with prostate cancer. His 20 years of industry experience has allowed him to gain core competencies in product development, regulatory approval, and commercial launch of novel digital biomarkers for radiopharmaceuticals. Prior to industry, Mr. Anand had eight years of academic and research training in Genitourinary Oncology at Memorial Sloan Kettering Cancer Center. He received his doctorate in Translational Medicine at Lund University, Sweden, and holds a graduate degree in biotechnology at Columbia University, New York, USA.